Ocular Discomfort (ocular + discomfort)

Distribution by Scientific Domains

Selected Abstracts

Relationship between eye symptoms and blepharospasm: A multicenter case,control study

Davide Martino MD
Abstract Although patients with primary blepharospasm (BSP) commonly report experiencing ocular symptoms before the onset of orbicular spasms, the precise frequency and pathogenic role of this subjective ocular discomfort are poorly understood. We conducted a multicenter case,control study to investigate symptoms related to disorders of the anterior segment of the eye, administering a questionnaire to 165 patients with BSP and 180 age- and gender-matched control patients with hemifacial spasm. On a validation sample, our questionnaire yielded high accuracy in detecting eye diseases (predominantly, dry eye syndrome) using detailed ophthalmological examination as the criterion. Logistic regression analysis indicated a significant association between ocular symptoms at disease onset and BSP. Ocular symptoms starting in the year preceding disease onset (short-latency symptoms) showed a stronger association with BSP than ocular symptoms occurring earlier in time (long-latency symptoms). The association was stronger when short-latency symptoms developed from 40 to 59 years of age, whereas this was not observed for long-latency symptoms. Our findings support the view that eye symptoms associated with BSP result from eye diseases and may be involved in the pathogenesis of BSP. The differential risk of developing BSP, based on age at onset of ocular symptoms, suggests that age and eye diseases may interact in giving rise to BSP. 2005 Movement Disorder Society [source]

Effect of oral contraceptives on tear physiology

Alan Tomlinson
Summary Variations in sex hormones due to the menstrual cycle (and oral contraceptives) were evaluated for their effect on tear physiology. Subjects were 18 females taking oral contraceptives or their age matched controls (no medication), aged 21,33 years. Symptoms of ocular discomfort (visual analog scale), tear film structure (TearScope), non-invasive tear thinning time (HirCal grid), evaporation rate (ServoMed evaporimeter), osmolality (Nanolitre Osmometer), tear turnover rate, tear volume (Fluorotron Master), and tear protein levels (HPLC) were measured around day 2 (D2), actually day 1,4 and day 19 (D19) actually day 18,21 of the cycle. No significant differences were found for any tear parameters between D2 and D19 for either pill users or controls alone, or in the comparison of pill users with controls. No effect on tear physiology was found for serum hormone changes induced by oral contraceptive use or by normal cyclic variations in healthy young females. [source]

2162: New aspects of the Slug Mucosal Irritation (SMI) assay: Detecting ocular stinging, itching and burning sensations

Purpose Our eyes are one of the most important senses. They are very sensitive and irritations may occur easily. A screening method for ocular discomfort would be very helpful in the development and refinement of formulations. In the past, the Slug Mucosal Irritation (SMI) assay demonstrated a relation between an increased mucus production (MP) in slugs and an elevated incidence of stinging, itching and burning (SIB) in human eyes. The aim of this study is to compare subjective ocular discomfort caused by shampoos evaluated in volunteers with results of the SIB-procedure. Methods The stinging potency of 1 artificial tear and 10 shampoos was evaluated with the SIB-procedure by placing 3 slugs per treatment group 3 times on 100 l of the test item. After each 15 min contact period, MP was measured. Evaluation of the results is based upon the total MP during 3 repeated contact periods. Experiments were repeated 3 times. A Human Eye Irritation test with the same test items will be set up (12-period cross-over study, 24 volunteers, study approved by an independent Commission for Medical Ethics, associated with Ghent University Hospital). The participants are dripped 10 l of a 5% or 10% shampoo dilution in water or the artificial tear in 1 eye, while in the other eye 10 l of water is administered. The evaluation of the test substances is done both by participants and the ophthalmologist at several time points. Conclusion With the obtained results we will be able to improve the newly developed protocol and examine the predictability with reference to non- and mildly irritating formulations in humans. We hope to conclude that the SIB-procedure is a good tool to predict clinical ocular discomfort. [source]

Low molecular weight analysis of tears using matrix assisted laser desorption ionization-time of flight mass spectrometry

Irene Mulvenna BSc
ABSTRACT Many low molecular weight substances in human tears, including protein and lipid species, have yet to be characterized. Some of these uncharacterized substances may well be important in the pathogenesis of ocular surface disease or in ocular discomfort. The aim of this study was to build a biochemical profile of low molecular weight species in tears, and to determine its repeatability. A total of 80 tear samples were collected from 11 subjects. Tear samples were dialysed to remove salts, added to a matrix of ,-cyano-4- hydroxycinnamic acid, and analysed using matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry. Species were separated based on their mass to charge ratio (m : z). The repeatability of the appearance of the different species was analysed using logistic regression and diurnal and day-to-day repeatability were ascertained. Peptides were identified in the range of 848,3897 Da. Of these, 39 peptides were found to be present in more than 10 / 80 samples. There was no diurnal variation in the peptides. All species were found to occur repeatably, with the exception of peptide 1653 Da. This study has demonstrated that the majority of low molecular weight species in tears are repeatably present and do not exhibit diurnal variation. Further study aims to characterize these species and to identify changes in tear profiles between subject groups. [source]